Human embryo models research may pave the way for improved IVF rates – study

The research could also lead to the development of therapeutics for infertility or non-hormonal contraceptives.

Nina Massey
Thursday 02 December 2021 16:00
Human embryo models research paves the way for improved IVF rates – study (Rivron/Nature/IMBA)
Human embryo models research paves the way for improved IVF rates – study (Rivron/Nature/IMBA)

New research on human embryo models paves the way for improving the success rate of IVF and creating a new non-hormonal, user-friendly contraception, a study suggests.

While hormonal contraceptives have been successfully used for a long time by many women, they can have side-effects, and their efficiency decreases if they are not faithfully taken on a daily basis.

Additionally, some women, such as breast cancer survivors, cannot be subjected to hormonal treatments.

Several human blastoids in culture (Rivron/Nature/IMBA)

In the new study, human blastoids – structures that mimic the early human embryo – are shown to replicate key phases of early development of the human embryo, including the attachment to cultured uterine cells.

The research could help increase the understanding of the early stages of human development and to develop therapeutics for infertility or contraceptives.

Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences researcher Nicolas Rivron and his team discovered molecules that could be candidates for contraceptives or fertility enhancers.

Dr Rivron said: “We want to make family planning easier, more convenient, and more adapted to current societal challenges.”

Within a week of fertilisation, human embryos form a ball of cells called a blastocyst, which implants into the uterine wall.

A faithful model of this developmental stage could support research to explore implantation and early development.

Using a SC144 molecule, the researchers found a promising pathway for a new generation of non-hormonal contraceptives.

They suggest these birth control pills could be taken only if necessary, removing the burden and stress associated with medications that need to be taken daily.

The need for only an occasional dose might also result in significantly fewer side effects compared to a daily hormonal pill, the scientists say.

Researchers were able to stimulate human stem cells to efficiently and faithfully self-organise into realistic models of the earliest stages of embryonic development.

These in vitro models, called blastoids, allowed them to begin studying the basic principles of early human development and to search for new therapeutics.

The blastoids were cultured for up to 13 days, at which point they contained about 300 cells.

Beyond contraception, the team also used blastoids to discover a new effect of a natural molecule, LPA.

According to the study, this molecule strongly improves the self-organisation of the stem cells and therefore might be used to boost the formation of natural embryos during In Vitro Fertilisation (IVF) procedures.

Dr Rivron said: “We hope we can use such molecules to improve the number and quality of IVF embryos, and the chance of becoming pregnant.

“Our goal is to empower women by allowing them to better control their fertility, whether they wish to prevent pregnancy or enhance their chances of having a child.”

He added: “By using blastoids we speed up research and make it more ethical.”

Dr Rivron concluded: “It is clear that scientific and biomedical knowledge will skyrocket with such realistic in vitro models for early pregnancy.”

The research is published in the Nature journal.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in